LAUREN MCCONEGHY: Open Payments
NPI 1831486752 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,312 in 55 payments from 18 companies in 2025. Trend: 2023 $1,481 · 2024 $1,591 · 2025 $1,312
Food & beverage: $1,222Education: $90
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $226 |
| LEO Pharma Inc. | 7 | $208 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $154 |
| GENZYME CORPORATION | 4 | $109 |
| Novartis Pharmaceuticals Corporation | 4 | $91 |
| Janssen Biotech, Inc. | 3 | $80 |
| Lilly USA, LLC | 3 | $77 |
| Galderma Laboratories, L.P. | 3 | $65 |
| Amgen Inc. | 2 | $47 |
| Arcutis Biotherapeutics, Inc. | 2 | $42 |
Products named: ADBRY, DUPIXENT, SKYRIZI, TREMFYA, RINVOQ, NEMLUVIO, TALTZ, OTEZLA.
Industry payments across FL — which companies pay providers there.
